{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:13:08Z","timestamp":1793110388138,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.psychres.2025.116506","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T02:25:27Z","timestamp":1745029527000},"page":"116506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A novel artificial intelligence-based methodology to predict non-specific response to treatment"],"prefix":"10.1016","volume":"348","author":[{"given":"Clotilde","family":"Guidetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo L.","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pappagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3916-9578","authenticated-orcid":false,"given":"Roberto","family":"Gomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116506_bib0019","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2217\/cer-2020-0013","article-title":"Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants","volume":"9","author":"Allan","year":"2020","journal-title":"J. Comp. Eff. Res."},{"key":"10.1016\/j.psychres.2025.116506_bib0015","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/j.pain.0000000000002791","article-title":"Open-label nondeceptive placebo analgesia is blocked by the opioid antagonist naloxone","volume":"164","author":"Benedetti","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.psychres.2025.116506_bib0027","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HRP.0b013e3182a75cc7","article-title":"Massachusetts General Hospital SAFER criteria for clinical trials and research","volume":"21","author":"Desseilles","year":"2013","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ctim.2012.12.010","article-title":"The placebo response in clinical trials\u2014The current state of play","volume":"21","author":"Enck","year":"2013","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.psychres.2025.116506_bib0010","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S2215-0366(16)30308-X","article-title":"Placebo response in depression: is it rising?","volume":"3","author":"Enck","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000069738","article-title":"The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach","volume":"72","author":"Fava","year":"2003","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.psychres.2025.116506_bib0026","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24m15265","article-title":"Efficacy and safety of Esmethadone (REL-1017) in patients with major depressive disorder and inadequate response to standard antidepressants: a phase 3 randomized controlled trial","volume":"85","author":"Fava","year":"2024","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0008","article-title":"Enrichment strategies for clinical trials to support determination of effectiveness of Human drugs and biological products","year":"2019","journal-title":"On"},{"key":"10.1016\/j.psychres.2025.116506_bib0004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2022.02.074","article-title":"Antidepressants in children and adolescents with major depressive disorder and the influence of placebo response: a meta-analysis","volume":"305","author":"Feeney","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116506_bib0016","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/JCP.0000000000000669","article-title":"Guarding the gate: remote structured assessments to enhance enrollment precision in depression trials","volume":"37","author":"Freeman","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2025.116506_bib0033","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70128","article-title":"Comparison of different machine learning methodologies for predicting the non-specific treatment response in Placebo controlled major depressive disorder clinical trials","volume":"18","author":"Gomeni","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.psychres.2025.116506_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115367","article-title":"A new method for analyzing clinical trials in depression based on individual propensity to respond to placebo estimated using artificial intelligence","volume":"327","author":"Gomeni","year":"2023","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.psychres.2025.116506_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41398-023-02443-0","article-title":"Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placebo","volume":"13","author":"Gomeni","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0024","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41398-023-02685-y","article-title":"Interpreting clinical trial outcomes complicated by placebo response with an assessment of false-negative and true-negative clinical trials in depression using propensity-weighting","volume":"13","author":"Gomeni","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0032","series-title":"Poster presentation at the 2024 ASCP Annual Meeting","article-title":"Propensity weighted approach to control the confounding effect of unbalanced distribution of placebo responders on the treatment effect in psychiatric clinical trials: an artificial intelligence driven trial simulation study","author":"Gomeni","year":"2024"},{"key":"10.1016\/j.psychres.2025.116506_bib0002","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.4088\/JCP.11r07485","article-title":"Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis","volume":"73","author":"Iovieno","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0003","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20r13682","article-title":"Vortioxetine versus placebo for major depressive disorder: a comprehensive analysis of the clinical trial dataset","volume":"82","author":"Iovieno","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0013","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/bmjebm-2019-111238","article-title":"Should antidepressants be used for major depressive disorder?","volume":"25","author":"Jakobsen","year":"2020","journal-title":"BMJ Evid. Based Med."},{"key":"10.1016\/j.psychres.2025.116506_bib0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/10543406.2022.2162067","article-title":"Reweighting estimators to extend the external validity of clinical trials: methodological considerations","volume":"33","author":"Kaizar","year":"2023","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.psychres.2025.116506_bib0029","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2016.12.041","article-title":"What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies","volume":"210","author":"Leucht","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2025.116506_bib0014","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0140-6736(78)92762-9","article-title":"The mechanism of placebo analgesia","volume":"2","author":"Levine","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2025.116506_bib0018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-244X-8-3","article-title":"Evaluating dose response from flexible dose clinical trials","volume":"8","author":"Lipkovich","year":"2008","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0007","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/clpt.2008.70","article-title":"Model-based approach and signal detection theory to evaluate the performance of recruitment centers in clinical trials with antidepressant drugs","volume":"84","author":"Merlo-Pich","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2025.116506_bib0021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0962280209340213","article-title":"Estimation of dose-response functions for longitudinal data using the generalized propensity score","volume":"21","author":"Moodie","year":"2012","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.psychres.2025.116506_bib0028","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ecolmodel.2004.03.013","article-title":"An accurate comparison of methods for quantifying variable importance in artificial neural networks using simulated data","volume":"178","author":"Olden","year":"2004","journal-title":"Ecol. Modell."},{"key":"10.1016\/j.psychres.2025.116506_bib0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","article-title":"Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD","volume":"19","author":"Papakostas","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.psychres.2025.116506_bib0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S2215-0366(23)00262-6","article-title":"Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development","volume":"10","author":"Pillinger","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0012","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1176\/appi.ajp.2012.12040474","article-title":"A model of placebo response in antidepressant clinical trials","volume":"170","author":"Rutherford","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0001","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/s41380-020-0646-3","article-title":"Success and efficiency of phase 2\/3 adjunctive trials for MDD funded by industry: a systematic review","volume":"25","author":"Salloum","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116506_bib0017","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/sim.5713","article-title":"Seven myths of randomisation in clinical trials","volume":"32","author":"Senn","year":"2013","journal-title":"Stat. Med."},{"key":"10.1016\/j.psychres.2025.116506_bib0006","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.euroneuro.2014.06.003","article-title":"Use of band-pass filter analysis to evaluate outcomes in an antidepressant trial for treatment-resistant patients","volume":"24","author":"Targum","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116506_bib0011","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125001544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125001544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:31:28Z","timestamp":1777955488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125001544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"alternative-id":["S0165178125001544"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116506","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel artificial intelligence-based methodology to predict non-specific response to treatment","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116506"}}